Indian hockey goalkeeper ban for two years for doping

New Delhi: The National Anti-Doping Agency (NADA) has banned hockey goalkeeper Akash Chitke for two years after he tested positive for a prohibited substance earlier this year.
Chitke was provisionally suspended by NADA from March 27 and the minimum sanction of two years was imposed by the Anti-Doping Disciplinary Panel (ADDP) after a final hearing on October 8.
Indian hockey goalkeeper Akash Chikte has been banned for two years after he tested positive for a prohibited substance.
The ban was enforced by the National Anti-Doping Agency. Chikte was suspended by NADA on March 27.
He tested positive for banned anabolic steroid (norandrosterone) during an out-of-competition test on February 27.

Five other athletes have also been handed four-year suspensions for violation of anti-doping code. The athletes include wrestler Amit, kabbadi player Pradeep Kumar, weightlifter Narayan Singh among others, according to Hindustan Times.
Chikte was a part of the Indian squad that won Asian Men’s Champions Trophy, as well as Asia Cup in Dhaka.
According to the NADA order, Chitke’s urine sample report had Adverse Analytical Findings (AAF) for 19-Norandrosterone (19 NA, metabolite of Nandrolone or its Precursor) at a concentration level greater than 15 ng/ml, Androgenic Anabolic Steroid, which is non-specified substance as per NADA/WADA prohibited list.
Once Chitke’s ‘B’ sample also showed similar AAF finding, a hearing was conducted on August 13. The player appeared before the panel and he said he had consumed medicines prescribed by his doctor for treatment of his index finger on his left foot.
While it was proved that Chitke neither sought Therapeutic Use Exemption Certificate (TUE Certificate) nor did he mention about the injection taken on the Doping Control Form, he was able to establish that he had no knowledge of the injection prescribed by the physician, whom he consulted in Pune.
Thus, he was able to avoid the maximum sanction of four years although NADA still has provision to appeal against this decision.
Photo: Hindustan Times